M-ficolin, an activator of the complement system, is the strongest predictor of both DAS28 remission and low disease activity in a cohort of 180 early DMARD naïve rheumatoid arthritis patients followed in the Opera-study.

C.G. Ammizbøll; J.C. Jensenius; T. Ellingsen; S. Thiel; Kim Hørslev-Petersen; Merete Lund Hetland; P. Junker; Julia Sidenius Johansen; Mikkel Østergaard; Jan Pødenphanth; K. Stengaard-Pedersen

M-ficolin, an activator of the complement system, is the strongest predictor of both DAS28 remission and low disease activity in a cohort of 180 early DMARD naïve rheumatoid arthritis patients followed in the Opera-study.

C.G. Ammizbøll
, J.C. Jensenius
, T. Ellingsen
, S. Thiel
, Kim Hørslev-Petersen
, Merete Lund Hetland
, P. Junker
, Julia Sidenius Johansen
, Mikkel Østergaard
, Jan Pødenphanth
, K. Stengaard-Pedersen

Originalsprog	Engelsk
Tidsskrift	Arthritis & Rheumatism
Vol/bind	64
Udgave nummer	10
Sider (fra-til)	S1065
Antal sider	1
ISSN	0004-3591
Status	Udgivet - 2012

Citationsformater

Ammizbøll, C. G., Jensenius, J. C., Ellingsen, T., Thiel, S., Hørslev-Petersen, K., Hetland, M. L., Junker, P., Johansen, J. S., Østergaard, M., Pødenphanth, J., & Stengaard-Pedersen, K. (2012). M-ficolin, an activator of the complement system, is the strongest predictor of both DAS28 remission and low disease activity in a cohort of 180 early DMARD naïve rheumatoid arthritis patients followed in the Opera-study. Arthritis & Rheumatism, 64(10), S1065.

M-ficolin, an activator of the complement system, is the strongest predictor of both DAS28 remission and low disease activity in a cohort of 180 early DMARD naïve rheumatoid arthritis patients followed in the Opera-study. / Ammizbøll, C.G.; Jensenius, J.C.; Ellingsen, T. et al.
I: Arthritis & Rheumatism, Bind 64, Nr. 10, 2012, s. S1065.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Ammizbøll, CG, Jensenius, JC, Ellingsen, T, Thiel, S, Hørslev-Petersen, K, Hetland, ML, Junker, P, Johansen, JS , Østergaard, M, Pødenphanth, J & Stengaard-Pedersen, K 2012, 'M-ficolin, an activator of the complement system, is the strongest predictor of both DAS28 remission and low disease activity in a cohort of 180 early DMARD naïve rheumatoid arthritis patients followed in the Opera-study.', Arthritis & Rheumatism, bind 64, nr. 10, s. S1065.

@article{f19376c297be453b80b7a707ce0ff4fc,

title = "M-ficolin, an activator of the complement system, is the strongest predictor of both DAS28 remission and low disease activity in a cohort of 180 early DMARD na{\"i}ve rheumatoid arthritis patients followed in the Opera-study.",

author = "C.G. Ammizb{\o}ll and J.C. Jensenius and T. Ellingsen and S. Thiel and Kim H{\o}rslev-Petersen and Hetland, \{Merete Lund\} and P. Junker and Johansen, \{Julia Sidenius\} and Mikkel {\O}stergaard and Jan P{\o}denphanth and K. Stengaard-Pedersen",

year = "2012",

language = "English",

volume = "64",

pages = "S1065",

journal = "Arthritis \& Rheumatism",

issn = "0004-3591",

publisher = "John Wiley \& Sons Inc.",

number = "10",

}

TY - ABST

T1 - M-ficolin, an activator of the complement system, is the strongest predictor of both DAS28 remission and low disease activity in a cohort of 180 early DMARD naïve rheumatoid arthritis patients followed in the Opera-study.

AU - Ammizbøll, C.G.

AU - Jensenius, J.C.

AU - Ellingsen, T.

AU - Thiel, S.

AU - Hørslev-Petersen, Kim

AU - Hetland, Merete Lund

AU - Junker, P.

AU - Johansen, Julia Sidenius

AU - Østergaard, Mikkel

AU - Pødenphanth, Jan

AU - Stengaard-Pedersen, K.

PY - 2012

Y1 - 2012

M3 - Conference abstract in journal

SN - 0004-3591

VL - 64

SP - S1065

JO - Arthritis & Rheumatism

JF - Arthritis & Rheumatism

IS - 10

ER -